# Adult Asthmatics and Acid Reflux

> **NCT00628953** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1400 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00628953
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2009-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00628953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00628953, "Adult Asthmatics and Acid Reflux". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00628953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*